Matrixyl: Palmitoyl Tripeptide-1, Palmitoyl Pentapeptide-4, and Collagen Research

Matrixyl encompasses palmitoylated peptides from Sederma (France): the original Palmitoyl Pentapeptide-4 (Pal-KTTKS) and Matrixyl 3000 combining Palmitoyl Tripeptide-1 (Pal-GHK) with Palmitoyl Tetrapeptide-7 (Pal-GQPR).

Why Palmitoylation Matters

The palmitoyl (C16:0 fatty acid) N-terminal modification increases lipophilicity, enabling stratum corneum penetration. Without it, the free peptides (GHK, KTTKS) are too hydrophilic to partition into the lipid-rich stratum corneum. With it, the peptides penetrate efficiently while retaining water-phase bioactivity in the aqueous dermis.

Pal-GHK: TGF-β Pathway

Pal-GHK delivers the GHK tripeptide through the stratum corneum. GHK and GHK-Cu both activate TGF-β receptor signalling → collagen type I, III, IV synthesis, fibronectin, and glycosaminoglycan production in fibroblasts.

Robinson LR et al. (*International Journal of Cosmetic Science*, 2005): Pal-GHK at 2 μM in reconstructed human skin increased collagen type I synthesis by ~40% over 5 days vs vehicle. A double-blind clinical trial showed 16% periorbital wrinkle depth improvement after 12 weeks of 5 ppm Pal-GHK.

Pal-KTTKS (Original Matrixyl): Procollagen Stimulation

KTTKS is derived from the type I procollagen C-propeptide. At 0.5-5 μM in fibroblast culture, Pal-KTTKS increased procollagen I synthesis 35-54%, fibronectin 20-30%, and laminin 15-25% above controls.

The pivotal clinical trial by Robinson LR et al. (*IJCS*, 2005) — double-blind, split-face, vehicle-controlled, n=93 women, Pal-KTTKS at 2 ppm twice daily for 12 weeks:

• Wrinkle volume: 13.9% improvement vs vehicle by optical profilometry at week 12

Matrixyl 3000: Complementary Mechanisms

Matrixyl 3000 combines Pal-GHK (collagen synthesis via TGF-β) with Pal-GQPR (anti-inflammatory via IL-6 suppression). Since UV-induced IL-6 upregulates MMPs that degrade collagen, the combination addresses both synthesis (supply) and protection from degradation (demand).

Practical Context

Peptide concentrations in commercial cosmetics typically range from 1-10 ppm — far below cell culture study concentrations. Most clinical evidence is proprietary and manufacturer-funded. Independent replication at specific concentrations is limited.

Matrixyl peptides are cosmetic ingredients, not drugs. This content is for scientific education.

<!-- deep-links-v1 -->

Related Collagen-Signaling and Skin Bioactive Peptides

Matrixyl operates within a large family of peptides studied for extracellular matrix remodeling and dermal regeneration. GHK-Tripeptide-1, the free-acid form of the copper-binding tripeptide, activates many of the same collagen and elastin synthesis pathways with additional wound-healing properties. AHK-Cu (Ala-His-Lys copper complex) is studied as an alternative copper-peptide to GHK-Cu for skin barrier and collagen support. Pal-AHK, the palmitoylated AHK form, improves dermal penetration for topical research applications. Pal-GHK, the palmitoylated GHK analogue, is the lipophilic variant most used in cosmeceutical research settings. Syn-Coll (Palmitoyl Tripeptide-5) works through a TGF-β pathway to stimulate type I and III collagen — a distinct mechanism from Matrixyl's matrikine approach.

Broader Matrix-Regulating Peptides

Tripeptide-29 (Pro-Gly-Pro) is a collagen-derived signal that promotes fibroblast activity and collagen turnover. Tripeptide-10 Citrulline targets fibrillin-1 to improve elastin fiber organization, addressing skin elasticity at the structural level. Tetrapeptide-21 (GEKG) stimulates fibronectin, hyaluronic acid, and collagen simultaneously in dermal fibroblast culture. Pentapeptide-18 (Leuphasyl) modulates enkephalin receptor signaling in skin to reduce expression-line wrinkle depth. Decapeptide-12 acts on melanocyte function to address pigmentation alongside its collagen-supporting role. Lipopeptide refers to a class of fatty acid-conjugated peptides that enhance membrane interaction and bioavailability in dermal tissue research.